Current recommendations for treatment and diagnosing of xerostomia in Sjögren’s syndrome

Authors

  • Oleh Zablotskyy Department of Oral Surgery and Periodontology, Poznań University of Medical Sciences, Poznań, Poland
  • Martyna Tomczyk Department of Oral Surgery and Periodontology, Poznań University of Medical Sciences, Poznań, Poland
  • Katarzyna Błochowiak Department of Oral Surgery and Periodontology, Poznań University of Medical Sciences, Poznań, Poland https://orcid.org/0000-0002-4882-8283

DOI:

https://doi.org/10.15584/ejcem.2019.4.12

Keywords:

saliva, Sjögren syndrome, xerostomia

Abstract

Introduction. Xerostomia is one of the most common and disturbing adverse effects of systemic diseases and their therapies. This complication markedly increases the risk for dental caries, difficulties with chewing, swallowing and sleep disorders with a significant impact on the patient’s quality of life. Sjögren’s syndrome (SS) is a systemic autoimmune disease that primarily affects the exocrine glands, resulting in dryness of the mouth due to lymphocytic infiltration of the salivary glands.

Aim. The aim of this paper is to present the current recommendations in diagnosing and treating SS-related xerostomia.

Material and methods. Analysis of literature.

Analysis of the literature. For the assessment of SS-related xerostomia, only an unstimulated salivary flow with rates of 0.1 mL/min is included in the current SS classification criteria. Saxon test, sialography, ultrasonography of salivary glands play supporting function. Treatment of SS -related xerostomia includes an application of secretagogues and the implementation of specific dental prophylaxis measures. Adjuvant therapies include herbal remedies, photobiomodulation, and acupuncture.

Conclusion. Treatment of SS requires multidisciplinary care. There is no fully effective treatment of xerostomia that provides immediate and long-lasting results. 

Downloads

Download data is not yet available.

References

Błochowiak KJ, Trzybulska D, Olewicz-Gawlik A, et.al. Levels of EGF and VEGF in patients with primary and secondary Sjögren’s syndrome. Adv Clin Exp Med. 2018;27(4):455-461.

Olewicz-Gawlik A, Polańska A, Trzybulska D, et al. Skin barrier function in patients with primary and secondary Sjögren’s syndrome. Acta Detmatovenerol Croat. 2018;26(2):153-156.

Błochowiak KJ, Olewicz-Gawlik A, Trzybulska D, et al. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren’s syndrome. Adv Clin Exp Med. 2017,26(5):835-842.

Błochowiak K, Olewicz-Gawlik A, Polańska A, et al. Oral mucosal manifestations in primary and secondary Sjögren’s syndrome and dry mouth syndrome. Post Derm Alerg. 2016,33(1):23-27.

Chagas Jaguar G, Divaldo Prado J, Campanhã D, Abreu Alves F. Clinical features and preventive theerapies of radiation-induced xerostomia in head and neck cancer patient: a literature review. Applied Cancer Research. 2017;37:31.

Chen X, Wu H, Wie W. Advances in the diagnosis and treatment of Sjogren's syndrome. Clinical Rheumatology. 2018;37(7):1743-1749.

Han P, Suarez-Durall P, Mulligan R. Dry mouth: A critical topic for older adult patients J Prosthodont Res. 2014;59(1):6-19.

Mayer E, Klapper HU, Nitschke I, Hahnel S. Observations, knowledge, and attitude towards treatment options in patients with dry mouth: a survey among German dentists. Clinical Oral Investigations. 2019. doi:10.1007/s00784-019-02858-4.

Gil-Montoya JA, Silvestre FJ, Barrios R, Silvestre-Rangil J. Treatment of xerostomia and hyposalivation in the elderly: A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21 (3):e355-366.

Wu X, Ren C, Zhou H, Zhang L, Juan C, Yang Y.Therapeutic effect of Zeng Ye decoction on primary Sjögren's syndrome via upregulation of aquaporin 1 and aquaporin 5 expression levels. Mol Med Rep. 2014;10(1):429-434

Shiboski CH, Shiboski SC, le Seror R, et al. American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome. A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Ann Rheum Dis. 2017;76:9-16.

Shiboski CH, Shiboski SC, Seror R. America College of Rheumatology/European League Against Rheumatism Classification Criteria for primary Sjögren’s syndrome. Arthritis Rheumatol. 2017,69:35-45.

Kamiński B. Laryngological manifestations of Sjögren’s syndrome. Reumatologia. 2019;57(1):37-44.

Wang SQ, Zhang LW, Wei P, Hua H. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis. BMC Muskuloskeletal Disord. 2017;18(1):186.

Humphrey SP, Williamson RT. A review of saliva: Normal composition, flow, and function. J Prosthet Dent. 2001;85(2):162-169.

Sumida T, Azuma N, Moriyama M, et al. Clinical practice guideline for Sjögren's syndrome 2017. Modern Rheumatology. 2018;28(3):383-408.

Dodds M, Roland S, Edgar M, Thornhill M. Saliva A review of its role in maintaining oral health and preventing dental disease. Bdj Team. 2015;2:15123.

Aoun G, Nasseh I, Berberi A. Evaluation of the oral component of Sjögren's syndrome: An overview. J Int Soc Prev Community Dent. 2016;6(4):278-284.

Dugonjić S, Stefanović D, Ethurović B, Spasić-Jokić V, Ajdinović B. Evaluation of diagnostic parameters from parotid and submandibular dynamic salivary glands scintigraphy and unstimulated sialometry in Sjögren's syndrome. Hell J Nucl Med. 2014;17(2):116-122.

Löfgren CD, Wickström C, Sonesson M, Lagunas PT, Christersson C. A systematic review of methods to diagnose oral dryness and salivary gland function. BMC Oral Health. 2012;12:29.

Bayetto K, Logan RM , authors. Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J. 2010;55,1:39-47.

Takahashi F, Morita O. Evaluation of the Usability of Modified Saxon Test. Prosthodont Res Pract. 2003;2:82-87.

Liu S, Chen W, Wang M et al. Quantitative Analysis of Parotid Gland Secretion Function in Sjögren's Syndrome Patients with Dynamic Magnetic Resonance Sialography. Korean J Radiol. 2019;20(3):498-504.

Ogura I, Sasaki Y, Oda T, Sue M, Hayama K. Magnetic Resonance Sialography and Salivary Gland Scintigraphy of Parotid Glands in Sjögren's Syndrome. Chin J Dent Res. 2018;21(1):63-68.

Charalambous A, Lambrinou E, Katodritis N, et al. The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: A feasibility randomized control trial. Eur J Oncol Nurs. 2017;27:1-8.

Del Papa N, Vitali C. Management of primary Sjögren's syndrome: recent developments and new classification criteria. Therapeutic advances in musculoskeletal disease. 2018;10(2):39-54.

Baer AN, Walitt B. Update on Sjogren Syndrome and Other Causes of Sicca in Older Adults. Rheum Dis Clin North Am. 2018;44(3):419-436.

Chengappa RK, Narayanan VS, Khan AM, Rakaraddi MP, Puttaswamy KA, Puttabuddi JH. Utility of two methodologies in the clinical assessment of oral dryness in postmenopausal women. J Midlife Health. 2016;7(3):114-118.

Watanabe M, Yamada C, Komagata Y, Kikuchi H, Hosono H, Itagaki F. New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life. J Pharm Health Care Sci. 2018;4:4.

Taniguchi A, Susa T, Kogo H, Iizuka-Kogo A, Yokoo S, Matsuzaki T. Long-term Pilocarpine Treatment Improves Salivary Flow in Irradiated Mice. Acta Histochem Cytochem. 2019;52(3):45-58.

Ng WF, Bowman SJ. Biologic therapies in primary Sjögren's syndrome. Curr Pharm Biotechnol. 2012;13(10):1997-2008.

Ching-Mao Ch, Hsueh-Ting Ch, Yau-Huei W, et al. The Core Pattern Analysis on Chinese Herbal Medicine for Sjögren’ssyndrome: A Nationwide Population-Based Study. Sci Rep. 2015;5:9541.

Park B, Noh H, Choi DJ. Herbal Medicine for Xerostomia in Cancer Patients: A Systematic Review of Randomized Controlled Trials. Integr Cancer Ther. 2018;17(2):179-191.

Wu X, Ren C, Zhou H, Zhang L, Juan C, Yang Y.Therapeutic effect of Zeng Ye decoction on primary Sjögren's syndrome via upregulation of aquaporin 1 and aquaporin 5 expression levels. Mol Med Rep. 2014;10(1):429-434.

Wu GL, Li TY, Fan YS, Yu GY, Chen J. Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome. Chin J Integr Med. 2013;19(9):696-700.

Hui L, Xinxue L, Jianping L, Flower A, Lewith G. Chinese Herbal Medicine in Treating Primary Sjögren's Syndrome: A Systematic Review of Randomized Trials. Evid Based Complement Alternat Med. 2012;2012:640658.

Zhuang L, Yang Z, Zeng X, et al. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review. Integr Cancer Ther. 2013;12(3):197-205.

Mathews SA, Kurien BT, Scofield RH , authors. Oral manifestations of Sjögren’s syndrome. J Dent Res. 2008;87p:308-318.

Mobadder ME, Farhat F, Mobadder WE, Nammour S. Photobiomodulation Therapy in the Treatment of Oral Mucositis, Dysgeusia and Oral Dryness as Side-Effects of Head and Neck Radiotherapy in a Cancer Patient: A Case Report. Dent. J (Basel). 2018;6(4):E64.

Karthikeyan V, Gopi Chander N, Kuttae Viswanathan A. A salivary sensor for the management of xerostomia in edentulous patients. J Prosthet Dent. 2019;121(3):384-386.

Delgado AJ, Olafsson VG. Acidic oral moisturizers with pH below 6.7 may be harmful to teeth depending on formulation: a short report. Clin Cosmet Investig Dent. 2017;9:81-83.

Palma LF, Gonnelli FAS, Marcucci M, Giordani AJ, Dias RS, Segreto RA, Segreto HRC. A novel method to evaluate salivary flow rates of head and neck cancer patients after radiotherapy: a pilot study. Braz J Otorhinolaryngol. 2018;84(2):227-231.

López-Pintor RM, Fernández Castro M, Hernández G, et al. Oral involvement in patients with primary Sjögren’s syndrome. Multidisciplinary care by dentists and rheumatologists. Reumatol Clin. 2015;11:387-394.

Downloads

Published

2019-12-30

How to Cite

Zablotskyy, O., Tomczyk, M., & Błochowiak, K. (2019). Current recommendations for treatment and diagnosing of xerostomia in Sjögren’s syndrome. European Journal of Clinical and Experimental Medicine, 17(4), 356–363. https://doi.org/10.15584/ejcem.2019.4.12

Issue

Vol. 17 No. 4 (2019)

Section

REVIEW PAPERS

License

Copyright (c) 2019 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.